NYSE:ZBH Zimmer Biomet (ZBH) Stock Price, News & Analysis $93.34 -1.27 (-1.34%) As of 10:28 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Zimmer Biomet Stock (NYSE:ZBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Zimmer Biomet alerts:Sign Up Key Stats Today's Range$92.16▼$94.0550-Day Range$87.50▼$101.4152-Week Range$79.12▼$106.88Volume130,790 shsAverage Volume2.25 million shsMarket Capitalization$17.80 billionP/E Ratio22.68Dividend Yield1.03%Price Target$104.42Consensus RatingHold Company Overview Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a medical technology company that develops, manufactures and markets products designed to treat musculoskeletal conditions. Its portfolio includes orthopedic implants and related systems for hip, knee, shoulder and other joint replacements, as well as products used in sports medicine, extremity care and trauma procedures. The company also provides robotic- and computer-assisted surgical technologies, digital solutions and other tools intended to support orthopedic procedures and patient care. Zimmer Biomet sells its products to hospitals, ambulatory surgery centers and healthcare professionals through direct sales organizations and distributors. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet serves healthcare providers and patients in the United States and international markets. The company was formed through the combination of Zimmer Holdings and Biomet in 2015. Ivan Tornos has served as Zimmer Biomet’s president and chief executive officer since 2023.AI Generated. May Contain Errors. Read More Zimmer Biomet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreZBH MarketRank™: Zimmer Biomet scored higher than 87% of companies evaluated by MarketBeat, and ranked 63rd out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingHold Consensus RatingZimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.26, and is based on 1 strong buy rating, 6 buy ratings, 14 hold ratings, and 2 sell ratings.Upside PotentialZimmer Biomet has a consensus price target of $104.42, representing about 10.2% upside from its current price of $94.78.Amount of Analyst CoverageZimmer Biomet has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Zimmer Biomet's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth5.27% Earnings GrowthEarnings for Zimmer Biomet are expected to grow by 5.27% in the coming year, from $8.54 to $8.99 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zimmer Biomet is 23.06, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Zimmer Biomet is 23.06, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.76.Price to Earnings Growth RatioZimmer Biomet has a PEG Ratio of 1.78. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioZimmer Biomet has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Zimmer Biomet's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.67% of the float of Zimmer Biomet has been sold short.Short Interest Ratio / Days to CoverZimmer Biomet has a short interest ratio ("days to cover") of 2.93, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Zimmer Biomet has recently decreased by 21.34%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldZimmer Biomet pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthZimmer Biomet does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Zimmer Biomet is 23.36%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 10.68% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.Read more about Zimmer Biomet's dividend. News and Social Media3.7 / 5News Sentiment0.86 News SentimentZimmer Biomet has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Zimmer Biomet this week, compared to 6 articles on an average week.Search InterestOnly 5 people have searched for ZBH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $295,050.00 in company stock.Percentage Held by Insiders1.28% of the stock of Zimmer Biomet is held by insiders.Percentage Held by Institutions88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Zimmer Biomet's insider trading history. Receive ZBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZBH Stock News HeadlinesZimmer Biomet (NYSE:ZBH) Insider Sells $295,050.00 in Stock4 hours ago | insidertrades.comZimmer Biomet Holdings Reiterates 2026 Outlook Amid Leadership ChangesSeptember 9 at 10:19 AM | finance.yahoo.comIt’s not about GreenlandThe petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar.September 10 at 1:00 AM | Porter & Company (Ad)Is Zimmer Biomet Holdings Inc (ZBH) a Bargain After 3.9% Drop? GF Value Says UndervaluedSeptember 8 at 8:00 PM | gurufocus.comZimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial TransformationSeptember 8 at 4:30 PM | prnewswire.comStryker drops after comments on vascular and ortho segmentsSeptember 8 at 2:16 PM | seekingalpha.comZimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $104.42 Consensus PT from AnalystsSeptember 2, 2026 | americanbankingnews.comZimmer Biomet - Showing Signs Of LifeSeptember 1, 2026 | seekingalpha.comSee More Headlines ZBH Stock Analysis - Frequently Asked Questions How have ZBH shares performed this year? Zimmer Biomet's stock was trading at $89.94 at the start of the year. Since then, ZBH shares have increased by 5.4% and is now trading at $94.7810. How were Zimmer Biomet's earnings last quarter? Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced its quarterly earnings data on Wednesday, August, 5th. The medical equipment provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.06. The business's revenue for the quarter was up 4.8% on a year-over-year basis. Read the conference call transcript. Does Zimmer Biomet have any subsidiaries? Zimmer Biomet subsidiaries include Respondwell, Clinical Graphics, CD Diagnostics, Medtech SAS, Compression Therapy Products, LDR Holding, Cayenne Medical, and more. Who are Zimmer Biomet's major shareholders? Top institutional investors of Zimmer Biomet include California State Teachers Retirement System (14.06%), BlackRock Inc. (8.07%), Primecap Management Co. CA (2.00%) and Van ECK Associates Corp (1.84%). Insiders that own company stock include Chad F Phipps, Sang Yi and Lori Winkler. View institutional ownership trends. How do I buy shares of Zimmer Biomet? Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zimmer Biomet own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zimmer Biomet investors own include Chevron (CVX), Bristol Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM). Company Calendar Record date for 7/31 Dividend6/25/2026Ex-Dividend for 7/31 Dividend6/25/2026Dividend Payable7/31/2026Last Earnings8/05/2026Today9/10/2026Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Dividend Payable10/30/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 ZBH's financial health is in the Green zone, according to TradeSmith. ZBH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:ZBH Previous SymbolNYSE:ZMH CIK1136869 Webwww.zimmerbiomet.com Phone(574) 267-6131Fax574-372-4988Employees17,000Year Founded1927Price Target and Rating Average Price Target for Zimmer Biomet$104.42 High Price Target$130.00 Low Price Target$90.00 Potential Upside/Downside+12.6%Consensus RatingHold Rating Score (0-4)2.26 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)$4.11 Trailing P/E Ratio22.61 Forward P/E Ratio10.86 P/E Growth1.78Net Income$705.20 million Net Margins9.48% Pretax Margin10.97% Return on Equity13.12% Return on Assets7.23% Debt Debt-to-Equity Ratio0.50 Current Ratio1.69 Quick Ratio0.94 Sales & Book Value Annual Sales$8.23 billion Price / Sales2.15 Cash Flow$13.52 per share Price / Cash Flow6.86 Book Value$64.11 per share Price / Book1.45Miscellaneous Outstanding Shares190,740,000Free Float188,297,000Market Cap$17.69 billion OptionableOptionable Beta0.47 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:ZBH) was last updated on 9/10/2026 by MarketBeat.com Staff. From Our PartnersGold Explorer Sits Between Barrick’s Nevada GiantsBarrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...Wall Street Logic | SponsoredShocking AI prediction from the “Billionaire Whisperer"Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Three under-the-radar companies are already building the infrastructure behind a 200 billion government-backed...Eagle Publishing | SponsoredThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredAmerican retirees will miss THIS. Big Banks just moved in.Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...Cedar Gold Group | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zimmer Biomet Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zimmer Biomet With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZBH Stock Alerts